13F
中

PMVP PMV PHARMACEUTICALS INC

2026Q1 · CUSIP 69353Y103 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
68
Δ holders QoQ
+5
Breadth percentile
Top 43%
Whale holders
30
Δ whales
+3
Inst. holding value
$46M
New positions
15
Closed positions
10
Price momentum (1Q)
—
Put / Call
0/1

Breadth history (34 quarters)

2020Q4: Δ+22 · h=74 2021Q1: Δ+8 · h=82 2021Q2: Δ+5 · h=87 2021Q3: Δ+5 · h=92 2021Q4: Δ+13 · h=105 2022Q1: Δ-6 · h=99 2022Q2: Δ+7 · h=106 2022Q3: Δ+14 · h=120 2022Q4: Δ-5 · h=115 2023Q1: Δ-4 · h=111 2023Q2: Δ-5 · h=106 2023Q3: Δ-1 · h=105 2023Q4: Δ-6 · h=99 2024Q1: Δ+1 · h=100 2024Q2: Δ-6 · h=94 2024Q3: Δ-19 · h=75 2024Q4: Δ-4 · h=71 2025Q1: Δ-15 · h=56 2025Q2: Δ+0 · h=56 2025Q3: Δ+8 · h=64 2025Q4: Δ-1 · h=63 2026Q1: Δ+5 · h=68 2020Q4: holders=74 2021Q1: holders=82 2021Q2: holders=87 2021Q3: holders=92 2021Q4: holders=105 2022Q1: holders=99 2022Q2: holders=106 2022Q3: holders=120 2022Q4: holders=115 2023Q1: holders=111 2023Q2: holders=106 2023Q3: holders=105 2023Q4: holders=99 2024Q1: holders=100 2024Q2: holders=94 2024Q3: holders=75 2024Q4: holders=71 2025Q1: holders=56 2025Q2: holders=56 2025Q3: holders=64 2025Q4: holders=63 2026Q1: holders=68 -22 -11 +0 +11 +22 5088126 20Q421Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q3 Top 9% -22.9% -45.1%
2022Q2 Top 19% -26.1% -51.6%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
1
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.48
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.38 2022-09-30: EPS -0.40 2022-12-31: EPS -0.42 2023-03-31: EPS -0.42 2023-06-30: EPS -0.38 2023-09-30: EPS -0.34 2023-12-31: EPS -0.30 2024-03-31: EPS -0.30 2024-06-30: EPS -0.02 2024-09-30: EPS -0.37 2024-12-31: EPS -0.45 2025-03-31: EPS -0.34 2025-06-30: EPS -0.41 2025-09-30: EPS -0.40 2025-12-31: EPS -0.33 2026-03-31: EPS -0.34 -0.50 -0.25 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)